Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A View from Riggs: Treatment Resistance and Patient Authority—Introduction to Paper IX: Integrative Psychodynamic Treatment of Psychotic Disorders

A View from Riggs: Treatment Resistance and Patient Authority—Introduction to Paper IX:... PLAKUN INTRODUCTION TO PAPER IX Eric M. Plakun, Series Editor In this ninth article in the Riggs series Jane Tillman addresses the treatment of psychotic spectrum disorders like schizophrenia. These are devastating disorders often thought of principally in terms of their acute phase presentations with delusions, hallucinations, paranoid beliefs, and unusual behavioral and mood manifestations. Yet, as we know, these disorders go much beyond the acute phase. Their diagnosis requires the presence of substantial and enduring prodromal or residual phase problems. As Tillman points out, these disorders are customarily treated with biological (i.e., pharmaceutical) treatments that, though effective in relieving many acute phase symptoms, leave affected individuals struggling with the problem of how to adapt and move on in their lives. Although many of the patients with psychotic spectrum disorders whom we see at Riggs have had substantial prior treatment courses, it is remarkable how often they have not had much exposure to individual psychodynamic therapy. These treatment resistant individuals live in an era in which biology reigns supreme. Treaters rarely think of the value of a psychodynamic approach, and even more rarely have any substantial training or experience with it. Such psychosocial treatment as is available often http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the American Academy of Psychoanalysis & Dynamic Psychiatry Guilford Press

A View from Riggs: Treatment Resistance and Patient Authority—Introduction to Paper IX: Integrative Psychodynamic Treatment of Psychotic Disorders

Loading next page...
 
/lp/guilford-press/a-view-from-riggs-treatment-resistance-and-patient-authority-kWS0yTjKGZ
Publisher
Guilford Press
Copyright
© The American Academy of Psychoanalysis and Dynamic Psychiatry
ISSN
1546-0371
DOI
10.1521/jaap.2008.36.4.737
pmid
19113963
Publisher site
See Article on Publisher Site

Abstract

PLAKUN INTRODUCTION TO PAPER IX Eric M. Plakun, Series Editor In this ninth article in the Riggs series Jane Tillman addresses the treatment of psychotic spectrum disorders like schizophrenia. These are devastating disorders often thought of principally in terms of their acute phase presentations with delusions, hallucinations, paranoid beliefs, and unusual behavioral and mood manifestations. Yet, as we know, these disorders go much beyond the acute phase. Their diagnosis requires the presence of substantial and enduring prodromal or residual phase problems. As Tillman points out, these disorders are customarily treated with biological (i.e., pharmaceutical) treatments that, though effective in relieving many acute phase symptoms, leave affected individuals struggling with the problem of how to adapt and move on in their lives. Although many of the patients with psychotic spectrum disorders whom we see at Riggs have had substantial prior treatment courses, it is remarkable how often they have not had much exposure to individual psychodynamic therapy. These treatment resistant individuals live in an era in which biology reigns supreme. Treaters rarely think of the value of a psychodynamic approach, and even more rarely have any substantial training or experience with it. Such psychosocial treatment as is available often

Journal

Journal of the American Academy of Psychoanalysis & Dynamic PsychiatryGuilford Press

Published: Dec 1, 2008

There are no references for this article.